News

San Antonio biotech acquires U.K. wound-care company

Acelity LP President and CEO Andrew Eckert says the company's acquisition of England's Crawford Healthcare ...

Kiromic founder says Houston biotech’s move to SA nearly a done deal

Houston-based immunotherapy company Kiromic is expected this month to approve moving its headquarters ...

Events

4th Annual SURF 2018

What: San Antonio Military Health System and Universities ResearchForum When: Thursday, June ...

SwRI 2018 International Human Performance Summit

June 30-July 1, 2018 The Summit will be hosted by Southwest Research Institute as part of its ongoing ...
News
City invests in stem-cell tech startup
November 21, 2013

By Peggy O'Hare, San Antonio Express-News

SAN ANTONIO - The city of San Antonio will invest $200,000 in a biotech startup founded to develop new advances in stem-cell technology.

City Council voted Thursday to invest in StemBioSys, Inc. through a grant to the San Antonio Economic Development Corporation. The money will be used for stem-cell research, development and manufacturing.

StemBioSys, founded in 2010, holds two patents and has three others pending. The company has four employees and will hire at least two more in the next year.

The company was formed by Dr. Xiao-Dong Chen, a professor at University of Texas Health Science Center at San Antonio, and Dr. Steven Davis, a San Antonio dermatologist, using licensed stem-cell technology Chen created at the university.

 

Stay informed. Subscribe to BioMed SA news alerts.